Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69
NCT03309761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158
Last updated 2025-11-21
Summary
The aim of the study is to describe an immune activation profile of people at risk of insulin resistance based on a wide range of markers which will allow easy identification of patients at risk.
Conditions
- Insulin Resistance
- Metabolic Syndrome X
Interventions
- OTHER
-
Blood test
6ml blood sample taken
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Eligibility
- Min Age
- 55 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-11
- Primary Completion
- 2018-08-20
- Completion
- 2018-08-20
Countries
- France
Study Locations
More Related Trials
-
Immune Profile and Complication Risk in Type 2 Diabetes
NCT00674271 ·Status: UNKNOWN
-
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
NCT01218061 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of IR in Overweight and Obese Adolescents
NCT05810883 ·Status: UNKNOWN
-
Implication of Metabolic and Genomic Modifications in Elderly Subjects
NCT00951392 ·Status: COMPLETED ·Phase: NA
-
Neutrophil-lymphocyte and Platelet-lymphocyte Ratios and Their Relations to Vascular Comlications and Glycemic Control in Patients With Type 2 Diabetes Attending The Diabetes Center of Assiut University Hospitals
NCT06073756 ·Status: NOT_YET_RECRUITING
-
Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)
NCT01432509 ·Status: COMPLETED ·Phase: NA
-
Metabolic Determinants of Cardiac Function
NCT03386864 ·Status: COMPLETED
-
The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care
NCT05553145 ·Status: COMPLETED
-
Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design
NCT02149056 ·Status: COMPLETED
-
Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes
NCT00172796 ·Status: UNKNOWN
-
Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting
NCT01807351 ·Status: COMPLETED
-
A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes
NCT00318032 ·Status: UNKNOWN ·Phase: NA
-
Diabetes Mellitus and Inflammatory Bowel Disease
NCT04105348 ·Status: UNKNOWN
-
Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications
NCT02212522 ·Status: UNKNOWN
-
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NCT05147961 ·Status: RECRUITING ·Phase: NA
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabetes
NCT04851223 ·Status: UNKNOWN
-
Diabetes Research on Patient Stratification
NCT03814915 ·Status: COMPLETED
-
Type 2 Diabetes and Acute Myocardial Infarction
NCT00926133 ·Status: UNKNOWN
-
Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose
NCT02440555 ·Status: COMPLETED
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Type 2 Diabetes and Alteration of Immune System of Intestinal Mucosa : Proof of Concept
NCT02811575 ·Status: COMPLETED
-
Study of Chronic Degenerative Diseases
NCT02495961 ·Status: COMPLETED
-
the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)
NCT04835974 ·Status: UNKNOWN ·Phase: NA
-
Morbidity in Newly Diagnosed type2 Diabetes in Adults
NCT02002091 ·Status: COMPLETED